Skip to main content
. Author manuscript; available in PMC: 2010 May 4.
Published in final edited form as: Epidemics. 2009 Mar 1;1(1):47–57. doi: 10.1016/j.epidem.2008.10.002

Figure 4.

Figure 4

HCV sero-prevalence in Phases 1 and 2 of the HCV epidemic under alternative parameter values for A. the infectivity of receptive needle sharing (RNS), ancillary equipment sharing (AES), acute HCV, and chronic HCV; B. the behavior of IDU entering the population at the start of Phase 2; and C. immunity to re-infection after spontaneous clearance of HCV. Parameters are defined in Table 1.